Applying Genomics to the Study of Complex Disease

ABSTRACT

The interest in dissecting the genetic and environmental components of complex human disease is growing, fueled by the emerging advances in the field of genomics and related disciplines. Improved understanding of the pathogenesis of complex liver diseases such as gallbladder stones, nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma remains a goal of the clinical and experimental hepatologist alike. Despite the scientific progress and technological advancement, elucidating the underlying mechanisms of complex hepatic diseases from the genomic standpoint will be demanding. Complexity of genomic structure and function, disease heterogeneity, influence of the environment on disease development and progression, and epigenetics all contribute to the challenge. To overcome these obstacles, novel conceptual frameworks regarding biological systems and human diseases are necessary in addition to a coordinated endeavor among different scientific disciplines. Deciphering in an integrated fashion the genomic, transcriptional, and translational aspects of the pathogenesis of complex liver diseases will lead to their better prediction, diagnostics, and treatment.

Systems biology - disease susceptibility - genetics

REFERENCES

• 1 Chakravarti A, Little P. Nature, nurture and human disease.  Nature. 2003;  421 412-414
• 2 Koonin E V. Orthologs, paralogs, and evolutionary genomics.  Annu Rev Genet. 2005;  39 309-338
• 3 Makalowski W. The human genome structure and organization.  Acta Biochim Pol. 2001;  48 587-598
• 4 Kitano H. Biological robustness.  Nat Rev Genet. 2004;  5 826-837
• 5 Dover G. How genomic and developmental dynamics affect evolutionary processes.  Bioessays. 2000;  22 1153-1159
• 6 Bortoluzzi S, Romualdi C, Bisognin A, Danieli G A. Disease genes and intracellular protein networks.  Physiol Genomics. 2003;  15 223-227
• 7 Gu Z, Steinmetz L M, Gu X et al.. Role of duplicate genes in genetic robustness against null mutations.  Nature. 2003;  421 63-66
• 8 Flatt T. The evolutionary genetics of canalization.  Q Rev Biol. 2005;  80 287-316
• 9 Nowak M A, Boerlijst M C, Cooke J, Smith J M. Evolution of genetic redundancy.  Nature. 1997;  388 167-171
• 10 Collins F S. The human genome project and the future of medicine.  Ann NY Acad Sci. 1999;  882 42-55 , discussion 56-65
• 11 Lazaridis K N, Juran B D. American Gastroenterological Association future trends committee report: the application of genomic and proteomic technologies to digestive disease diagnosis and treatment and their likely impact on gastroenterology clinical practice.  Gastroenterology. 2005;  129 1720-1752
• 12 Strohman R. Maneuvering in the complex path from genotype to phenotype.  Science. 2002;  296 701-703
• 13 MacGregor A J, Snieder H, Schork N J, Spector T D. Twins: novel uses to study complex traits and genetic diseases.  Trends Genet. 2000;  16 131-134
• 14 Jiang Y H, Bressler J, Beaudet A L. Epigenetics and human disease.  Annu Rev Genomics Hum Genet. 2004;  5 479-510
• 15 Lander E S, Linton L M, Birren B et al.. Initial sequencing and analysis of the human genome.  Nature. 2001;  409 860-921
• 16 Kruglyak L, Nickerson D A. Variation is the spice of life.  Nat Genet. 2001;  27 234-236
• 17 Crawford D C, Akey D T, Nickerson D A. The patterns of natural variation in human genes.  Annu Rev Genomics Hum Genet. 2005;  6 287-312
• 18 Tabor H K, Risch N J, Myers R M. Opinion: candidate-gene approaches for studying complex genetic traits-practical considerations.  Nat Rev Genet. 2002;  3 391-397
• 19 Glatt C E, DeYoung J A, Delgado S et al.. Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes.  Nat Genet. 2001;  27 435-438
• 20 Waterston R H, Lindblad-Toh K, Birney E et al.. Initial sequencing and comparative analysis of the mouse genome.  Nature. 2002;  420 520-562
• 21 Moens P B. The double-stranded DNA helix in recombination at meiosis.  Genome. 2003;  46 936-937
• 22 International HapMap Consortium . A haplotype map of the human genome.  Nature. 2005;  437 1299-1320
• 23 Stumpf M P. Haplotype diversity and the block structure of linkage disequilibrium.  Trends Genet. 2002;  18 226-228
• 24 Gabriel S B, Schaffner S F, Nguyen H et al.. The structure of haplotype blocks in the human genome.  Science. 2002;  296 2225-2229
• 25 Cardon L R, Abecasis G R. Using haplotype blocks to map human complex trait loci.  Trends Genet. 2003;  19 135-140
• 26 Johnson G C, Esposito L, Barratt B J et al.. Haplotype tagging for the identification of common disease genes.  Nat Genet. 2001;  29 233-237
• 27 Zeggini E, Rayner W, Morris A P et al.. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets.  Nat Genet. 2005;  37 1320-1322
• 28 Carlson C S, Eberle M A, Kruglyak L, Nickerson D A. Mapping complex disease loci in whole-genome association studies.  Nature. 2004;  429 446-452
• 29 Holtzman N A. Putting the search for genes in perspective.  Int J Health Serv. 2001;  31 445-461
• 30 Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease.  Nat Genet. 2003;  33(suppl) 228-237
• 31 Mayeux R. Mapping the new frontier: complex genetic disorders.  J Clin Invest. 2005;  115 1404-1407
• 32 Majumder P P, Ghosh S. Mapping quantitative trait loci in humans: achievements and limitations.  J Clin Invest. 2005;  115 1419-1424
• 33 Maraganore D M, de Andrade M, Lesnick T G et al.. High-resolution whole-genome association study of Parkinson disease.  Am J Hum Genet. 2005;  77 685-693
• 34 Puppala S, Dodd G D, Fowler S et al.. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.  Am J Hum Genet. 2006;  78 377-392
• 35 Whitcomb D C, Aoun E, Vodovotz Y et al.. Evaluating disorders with a complex genetics basis: the future roles of meta-analysis and systems biology.  Dig Dis Sci. 2005;  50 2195-2202
• 36 Palmer L J, Cardon L R. Shaking the tree: mapping complex disease genes with linkage disequilibrium.  Lancet. 2005;  366 1223-1234
• 37 Gordon D, Finch S J. Factors affecting statistical power in the detection of genetic association.  J Clin Invest. 2005;  115 1408-1418
• 38 Vineis P, McMichael A J. Bias and confounding in molecular epidemiological studies: special considerations.  Carcinogenesis. 1998;  19 2063-2067
• 39 Shephard N, John S, Cardon L et al.. Will the real disease gene please stand up?.  BMC Genet. 2005;  6(suppl 1) S66
• 40 Colhoun H M, McKeigue P M, Davey Smith G. Problems of reporting genetic associations with complex outcomes.  Lancet. 2003;  361 865-872
• 41 Cardon L R, Bell J I. Association study designs for complex diseases.  Nat Rev Genet. 2001;  2 91-99
• 42 Collins F S. The case for a US prospective cohort study of genes and environment.  Nature. 2004;  429 475-477
• 43 Montague C T, Farooqi I S, Whitehead J P et al.. Congenital leptin deficiency is associated with severe early-onset obesity in humans.  Nature. 1997;  387 903-908
• 44 Dean M, Carrington M, Winkler C et al.. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.  Science. 1996;  273 1856-1862
• 45 Dean M. Approaches to identify genes for complex human diseases: lessons from Mendelian disorders.  Hum Mutat. 2003;  22 261-274
• 46 Laird P W. The power and the promise of DNA methylation markers.  Nat Rev Cancer. 2003;  3 253-266
• 47 Rakyan V K, Hildmann T, Novik K L et al.. DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project.  PLoS Biol. 2004;  2 e405
• 48 Knudson A G. Antioncogenes and human cancer.  Proc Natl Acad Sci USA. 1993;  90 10914-10921
• 49 Randolph T R. Chronic myelocytic leukemia. Part II: approaches to and molecular monitoring of therapy.  Clin Lab Sci. 2005;  18 49-56
• 50 Gonzalez E, Kulkarni H, Bolivar H et al.. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.  Science. 2005;  307 1434-1440
• 51 Kirkwood T B. Understanding the odd science of aging.  Cell. 2005;  120 437-447
• 52 Suh Y, Vijg J. Maintaining genetic integrity in aging: a zero sum game.  Antioxid Redox Signal. 2006;  8 559-571